Closing the access gap for health innovations: an open licensing proposal for universities

This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries. A recent deal between Emory University, Gilead Sciences, and Royalty Pharma is used as an example to illustrate how 'equitable access licensing' could be put into practice.

Published in Globalization & Health on February 1, 2007. Original version available from http://www.globalizationandhealth.com/content/3/1/1.